## Abstract ## Background The management of initially bulky nodal disease after primary nonsurgical treatment for stage IV head and neck squamous cell carcinoma (HNSCC) continues to be a subject of debate. ## Methods A retrospective chart review of neck management in patients after chemoradiatio
Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck
โ Scribed by Tamar Kotz; Rosemary Costello; Yi Li; Marshall Roy Posner
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 732 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background.
Swallowing dysfunction is a common side effect of chemoradiation.
Methods.
Twelve patients with stage III or IV squamous cell carcinoma of the head and neck were enrolled. Videofluorographic swallowing studies were performed before initiation of chemoradiation to provide baseline swallowing function data. Postchemoradiation videofluorographic swallowing studies were performed from 1 to 14 weeks after the completion of treatment (mean, 8 weeks).
Results.
Changes in swallowing physiology after treatment included decreased base of tongue to posterior pharyngeal wall contact (p = .0010) and reduced pharyngeal contraction (p = .0313), resulting in impaired bolus transport through the pharynx. In addition, decreased laryngeal elevation (p = .0039), decreased laryngeal vestibule closure (p = .0078), and laryngeal penetration (p = .0078) were present. Bolus volume did not have a significant effect on swallowing ability. Aspiration was observed in four patients.
Conclusions.
Organ preservation treatment impairs movement of structures essential for normal swallowing. Prophylactic swallowing exercises may benefit these patients. ยฉ 2004 Wiley Periodicals, Inc. Head Neck 26: 365โ372, 2004
๐ SIMILAR VOLUMES
## Abstract Fiftyโone patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__โplatinum (DDP), bleomycin (Bleo), ยฑ high dose methotrexate (MTX). Thirtyโth
## Abstract ## Background. Salvage surgery after concomitant chemoradiation therapy (CCRT) for patients with head and neck squamous cell carcinomas (HNSCC) is challenging because of its associated morbidity/mortality and the poor prognoses of these patients. ## Methods. The outcome analysis of p
To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta
Background. Our primary objective was to determine the role of neck dissection following concomitant chemoradiation (CRT) for advanced stage III-IV head and neck squamous cell carcinoma (HNSCC). Methods. One hundred eighty-four patients with HNSCC treated with CRT were included. One hundred twenty-